Mary Beth Pelletier

Dr. Mary Beth Pelletier is currently the Head of Global QC Analytical Technology at Biogen in Research Triangle Park, NC, USA, where her team supports development, optimization, validation, transfer, troubleshooting, and lifecycle maintenance of analytical procedures for Biogen’s biologics and gene therapy portfolio from Phase 1 throughout the commercial lifecycle. Mary Beth is also a topic lead for the ICH Expert Working Group for Q2(R2) and Q14 representing BIO. She received her bachelor’s degree in chemistry from Northwestern University in Evanston, IL and her Ph.D. in chemistry from The Scripps Research Institute in La Jolla, CA. Prior to Biogen, Mary Beth held positions in biologics formulation and analytical development.